Fecal microbiota transplantation: past, present and future
- PMID: 23041678
- DOI: 10.1097/MOG.0b013e32835a4b3e
Fecal microbiota transplantation: past, present and future
Abstract
Purpose of review: Fecal microbiota transplantation (FMT) re-establishes a balanced intestinal flora with resultant cure of recurrent Clostridium difficile infection (RCDI). FMT has also been used to treat other gastrointestinal (GI) diseases including inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), and chronic constipation and a variety of non-GI disorders. The purpose of this review is to discuss the intestinal microbiota and FMT treatment of GI and non-GI diseases.
Recent findings: It is known that an imbalanced intestinal microbiota predisposes to CDI, IBD and IBS. The complex role of intestinal microbiota to maintain health, however, is a newer concept that is being increasingly studied. The microbiome plays an important role in cellular immunity and energy metabolism and has been implicated in the pathogenesis of non-GI autoimmune diseases, chronic fatigue syndrome, obesity and even some neuropsychiatric disorders.
Summary: FMT is a highly effective cure for RCDI, but increased knowledge of the intestinal microbiota in health maintenance, as well as controlled trials of FMT in a wide range of disorders are needed before FMT can be accepted and applied clinically.
Similar articles
-
An overview of fecal microbiota transplantation: techniques, indications, and outcomes.Gastrointest Endosc. 2013 Aug;78(2):240-9. doi: 10.1016/j.gie.2013.03.1329. Epub 2013 May 2. Gastrointest Endosc. 2013. PMID: 23642791 Review. No abstract available.
-
Application and development of fecal microbiota transplantation in the treatment of gastrointestinal and metabolic diseases: A review.Saudi J Gastroenterol. 2023 Jan-Feb;29(1):3-11. doi: 10.4103/sjg.sjg_131_22. Saudi J Gastroenterol. 2023. PMID: 36412458 Free PMC article. Review.
-
Therapeutic potential of fecal microbiota transplantation.Gastroenterology. 2013 Nov;145(5):946-53. doi: 10.1053/j.gastro.2013.08.058. Epub 2013 Sep 7. Gastroenterology. 2013. PMID: 24018052 Review.
-
Fecal microbiota transplantation: facts and controversies.Curr Opin Gastroenterol. 2014 Jan;30(1):34-9. doi: 10.1097/MOG.0000000000000024. Curr Opin Gastroenterol. 2014. PMID: 24241245 Review.
-
Is fecal microbiota transplantation (FMT) an effective treatment for patients with functional gastrointestinal disorders (FGID)?Neurogastroenterol Motil. 2015 Jan;27(1):19-29. doi: 10.1111/nmo.12479. Epub 2014 Nov 25. Neurogastroenterol Motil. 2015. PMID: 25424663 Review.
Cited by
-
Inference of Network Dynamics and Metabolic Interactions in the Gut Microbiome.PLoS Comput Biol. 2015 Jun 23;11(5):e1004338. doi: 10.1371/journal.pcbi.1004338. eCollection 2015 May. PLoS Comput Biol. 2015. PMID: 26102287 Free PMC article.
-
A Proteogenomic Approach to Unveiling the Complex Biology of the Microbiome.Int J Mol Sci. 2024 Sep 28;25(19):10467. doi: 10.3390/ijms251910467. Int J Mol Sci. 2024. PMID: 39408795 Free PMC article. Review.
-
Gut microbiota differs between treatment outcomes early after fecal microbiota transplantation against recurrent Clostridioides difficile infection.Gut Microbes. 2022 Jan-Dec;14(1):2084306. doi: 10.1080/19490976.2022.2084306. Gut Microbes. 2022. PMID: 36519447 Free PMC article. Clinical Trial.
-
CircNF1-419 improves the gut microbiome structure and function in AD-like mice.Aging (Albany NY). 2020 Jan 6;12(1):260-287. doi: 10.18632/aging.102614. Epub 2020 Jan 6. Aging (Albany NY). 2020. Retraction in: Aging (Albany NY). 2023 Jul 30;15(14):7333. doi: 10.18632/aging.204905. PMID: 31905172 Free PMC article. Retracted.
-
The "Culture" of Pain Control: A Review of Opioid-Induced Dysbiosis (OID) in Antinociceptive Tolerance.J Pain. 2020 Jul-Aug;21(7-8):751-762. doi: 10.1016/j.jpain.2019.11.015. Epub 2019 Dec 11. J Pain. 2020. PMID: 31841668 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous